OptiBiotix Health PLC
Company Profile
Business description
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.
Contact
Innovation Centre, Innovation Way
Heslington
YorkYO10 5DG
GBRT: +44 7721978218
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
9
Stocks News & Analysis
stocks
Margins have bottomed for ASX listed consumer goods company
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,008.40 | 41.30 | -0.46% |
| CAC 40 | 8,400.11 | 21.03 | -0.25% |
| DAX 40 | 25,139.69 | 153.87 | 0.62% |
| Dow JONES (US) | 51,712.71 | 148.01 | 0.29% |
| FTSE 100 | 10,437.85 | 74.58 | 0.72% |
| HKSE | 23,492.31 | 276.21 | -1.16% |
| NASDAQ | 26,166.60 | 351.33 | -1.32% |
| Nikkei 225 | 71,429.07 | 924.89 | -1.28% |
| NZX 50 Index | 13,456.71 | 10.66 | 0.08% |
| S&P 500 | 7,472.79 | 27.79 | -0.37% |
| S&P/ASX 200 | 8,805.50 | 29.60 | -0.34% |
| SSE Composite Index | 4,147.55 | 15.55 | -0.37% |